Skip to main content
. 2020 Jul 2;55(1):118–128. doi: 10.1007/s43441-020-00196-2

Figure 3.

Figure 3.

Certificate of Pharmaceutical Product (CPP) Submission Timing, Relative to New Active Substance (NAS) Marketing Authorization Application (MAA), Based on a Agency Information and b Company Practice.